• Je něco špatně v tomto záznamu ?

PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing

JR. Taube, K. Sperle, L. Banser, P. Seeman, BC. Cavan, JY. Garbern, GM. Hobson,

. 2014 ; 23 (20) : 5464-5478.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023358

Grantová podpora
NT14348 MZ0 CEP - Centrální evidence projektů

Alternative splicing of the proteolipid protein 1 gene (PLP1) produces two forms, PLP1 and DM20, due to alternative use of 5' splice sites with the same acceptor site in intron 3. The PLP1 form predominates in central nervous system RNA. Mutations that reduce the ratio of PLP1 to DM20, whether mutant or normal protein is formed, result in the X-linked leukodystrophy Pelizaeus-Merzbacher disease (PMD). We investigated the ability of sequences throughout PLP1 intron 3 to regulate alternative splicing using a splicing minigene construct transfected into the oligodendrocyte cell line, Oli-neu. Our data reveal that the alternative splice of PLP1 is regulated by a long-distance interaction between two highly conserved elements that are separated by 581 bases within the 1071-base intron 3. Further, our data suggest that a base-pairing secondary structure forms between these two elements, and we demonstrate that mutations of either element designed to destabilize the secondary structure decreased the PLP1/DM20 ratio, while swap mutations designed to restore the structure brought the PLP1/DM20 ratio to near normal levels. Sequence analysis of intron 3 in families with clinical symptoms of PMD who did not have coding-region mutations revealed mutations that segregated with disease in three families. We showed that these patient mutations, which potentially destabilize the secondary structure, also reduced the PLP1/DM20 ratio. This is the first report of patient mutations causing disease by disruption of a long-distance intronic interaction controlling alternative splicing. This finding has important implications for molecular diagnostics of PMD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023358
003      
CZ-PrNML
005      
20181030101524.0
007      
ta
008      
150709s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddu271 $2 doi
035    __
$a (PubMed)24890387
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Taube, Jennifer R $u Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
245    10
$a PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing / $c JR. Taube, K. Sperle, L. Banser, P. Seeman, BC. Cavan, JY. Garbern, GM. Hobson,
520    9_
$a Alternative splicing of the proteolipid protein 1 gene (PLP1) produces two forms, PLP1 and DM20, due to alternative use of 5' splice sites with the same acceptor site in intron 3. The PLP1 form predominates in central nervous system RNA. Mutations that reduce the ratio of PLP1 to DM20, whether mutant or normal protein is formed, result in the X-linked leukodystrophy Pelizaeus-Merzbacher disease (PMD). We investigated the ability of sequences throughout PLP1 intron 3 to regulate alternative splicing using a splicing minigene construct transfected into the oligodendrocyte cell line, Oli-neu. Our data reveal that the alternative splice of PLP1 is regulated by a long-distance interaction between two highly conserved elements that are separated by 581 bases within the 1071-base intron 3. Further, our data suggest that a base-pairing secondary structure forms between these two elements, and we demonstrate that mutations of either element designed to destabilize the secondary structure decreased the PLP1/DM20 ratio, while swap mutations designed to restore the structure brought the PLP1/DM20 ratio to near normal levels. Sequence analysis of intron 3 in families with clinical symptoms of PMD who did not have coding-region mutations revealed mutations that segregated with disease in three families. We showed that these patient mutations, which potentially destabilize the secondary structure, also reduced the PLP1/DM20 ratio. This is the first report of patient mutations causing disease by disruption of a long-distance intronic interaction controlling alternative splicing. This finding has important implications for molecular diagnostics of PMD.
650    12
$a alternativní sestřih $7 D017398
650    _2
$a párování bází $7 D020029
650    _2
$a buněčné linie $7 D002460
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a introny $7 D007438
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a molekulární modely $7 D008958
650    _2
$a mutace $7 D009154
650    _2
$a myelinový proteolipidový protein $x genetika $x metabolismus $7 D018991
650    _2
$a konformace nukleové kyseliny $7 D009690
650    _2
$a oligodendroglie $x metabolismus $7 D009836
650    _2
$a rodokmen $7 D010375
650    _2
$a Pelizaeusova-Merzbacherova nemoc $x genetika $7 D020371
650    _2
$a messenger RNA $x chemie $x metabolismus $7 D012333
650    _2
$a sekvenční analýza DNA $7 D017422
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sperle, Karen $u Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
700    1_
$a Banser, Linda $u Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
700    1_
$a Seeman, Pavel, $u Department of Child Neurology, DNA Laboratory, 2nd School of Medicine, Charles University and University Hospital Motol, 150 06 Prague 5, Czech Republic. $d 1966- $7 xx0037870
700    1_
$a Cavan, Barbra Charina V $u Department of Pediatrics, Cebu Institute of Medicine, 6000 Cebu City, Philippines.
700    1_
$a Garbern, James Y $u Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA.
700    1_
$a Hobson, Grace M $u Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA, Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA and Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA ghobson@nemours.org.
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 23, č. 20 (2014), s. 5464-5478
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24890387 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20181030102041 $b ABA008
999    __
$a ok $b bmc $g 1083696 $s 906351
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 23 $c 20 $d 5464-5478 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
GRA    __
$a NT14348 $p MZ0
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...